Digital Twins for Healthcare and Biomedical Industry Applications

The concept of digital twins combined with engineering simulation is an exciting framework for professionals working to improve medical devices in biomedicine. A digital twin acts as a virtual representation or digital replica of a physical object, system, processes which can include parts of the human body. Digital twins can be applied to medical devices to replicate the physical structures and functionality of medical devices, monitor their real time performance, and simulate and test the performance of medical devices under various conditions.

Join us on 3 October as we bring together distinguished speakers to discuss how they are using state-of-the-art engineering simulation technology to help realise digital twins within the healthcare and biomedical industries. Speakers and examples presented will be from both industry and academia, including Prof. David Fletcher from University of Sydney and LEAP Australia, Associate Professor Kiao Inthavong from RMIT University along with representatives from Leica Biosystems and Invetech. Applications discussed will include patient-specific modelling of aneurysms, arterial grafts, heart valves, nasal/respiratory pathways and inhalers/drug delivery, as well as general use of simulation in the design & development of a range of medical devices.

This is an opportunity to see how the convergence of data and engineering is advancing the development of new technologies for improved healthcare and driving innovation with the medical device industry within Australia.

This is a free event held in-person and online.

THE PRESENTERS:

Professor David Fletcher

David Fletcher has been performing CFD simulation for more than 40 years across a wide range of applications. He is an Adjunct Professor in the School of Chemical and Biomolecular Engineering at The University of Sydney and the Senior CFD Specialist at LEAP Australia. He has a strong focus on biomedical applications, including the study of Syringomyelia (with Neura, UNSW), Arterial grafting (with University of Queensland), incorporation of 4D flow data into simulation (with The Charles Perkin Centre, The University of Sydney), dry particle inhaler design and optimisation (with Macquarie and Monash universities), nasal flow and drug delivery (with RMIT University) and is part of a large team developing a novel heart valve for children, based at the University of Sydney.

Professor Kiao Inthavong

Kiao Inthavong received his PhD from RMIT in 2009, and is currently an Associate Professor at the School of Engineering. His research is in computational and experimental fluid-particle and multiphase flow dynamics with applications in nasal drug delivery, respiratory health, and air-quality in the indoor built environment. He has over 140-peer reviewed publications including scholarly books with Springer (incl. “Computational Fluid Particle Dynamics in the Respiratory System”)